IRIS
LANDRISCINA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.850
EU - Europa 6.030
AS - Asia 2.322
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 12
SA - Sud America 10
AF - Africa 1
Totale 15.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.821
IE - Irlanda 2.277
CN - Cina 1.860
UA - Ucraina 1.555
SE - Svezia 952
IT - Italia 365
TR - Turchia 278
FR - Francia 271
FI - Finlandia 267
GB - Regno Unito 137
IN - India 135
DE - Germania 89
BE - Belgio 41
RU - Federazione Russa 29
NL - Olanda 21
CA - Canada 20
EU - Europa 18
VN - Vietnam 13
JP - Giappone 11
AU - Australia 10
AT - Austria 9
IR - Iran 6
CL - Cile 5
CZ - Repubblica Ceca 4
MX - Messico 4
SG - Singapore 4
BR - Brasile 3
CR - Costa Rica 3
ES - Italia 3
HK - Hong Kong 3
ID - Indonesia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
NZ - Nuova Zelanda 2
AR - Argentina 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 15.245
Salva come PNG Salva come JPEG
Città #
Dublin 2.275
Chandler 1.332
Jacksonville 1.108
Dearborn 754
Nyköping 639
Nanjing 579
Princeton 247
Beijing 237
Nanchang 221
Ashburn 217
Wilmington 215
San Mateo 199
New York 180
Boardman 122
Shenyang 113
Ann Arbor 111
Kunming 109
Hebei 106
Des Moines 105
Helsinki 81
Tianjin 80
Woodbridge 78
Jiaxing 69
Changsha 66
Jinan 47
Hangzhou 46
Foggia 40
Brussels 39
Los Angeles 33
Seattle 29
Zhengzhou 26
Ningbo 24
Washington 23
Auburn Hills 19
Norwalk 19
Guangzhou 18
Lanzhou 18
Taizhou 18
London 15
Bari 14
Changchun 14
Orange 14
Hilden 13
Palermo 13
Dong Ket 12
Falls Church 12
Fuzhou 12
Pune 12
Redwood City 11
Saint Petersburg 11
Matera 9
Rome 9
Vienna 9
Augusta 8
Toronto 8
Borås 7
Hefei 7
San Severo 7
Kocaeli 6
Philadelphia 6
Shanghai 6
Stevenage 6
Chicago 5
Chieti 5
Hobart 5
Monza 5
Potenza 5
Avigliano 4
Bacoli 4
Brno 4
Edmonton 4
Leawood 4
Milan 4
Rockville 4
San Giovanni Rotondo 4
Shaoxing 4
Turin 4
Andria 3
Cologne 3
Jakarta 3
Naples 3
Napoli 3
Nuremberg 3
Palombara Sabina 3
Paris 3
Simi Valley 3
Arese 2
Auckland 2
Bitonto 2
Bongaigaon 2
Boston 2
Catanzaro 2
Clearwater 2
Conegliano 2
Deventer 2
Ferrandina 2
Grumo Appula 2
Guiyang 2
Houston 2
Istanbul 2
Totale 10.003
Salva come PNG Salva come JPEG
Nome #
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 117
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits 108
Adjuvant treatment for EGFR-mutated non-small cell lung cancer: Do we have a major breakthrough? 106
THE CALCIUM-BINDING PROTEIN S100A13 CORRELATES WITH AN ANGIOGENIC PHENOTYPE IN MALIGNANT MELANOMA 102
TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells 101
Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine. 100
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 99
Modulazione della MnSOD con LPS e ferro in HCC di ratto. 97
FUNCTIONAL CHARACTERIZATION OF TRAP1 PATHWAY IN MULTIDRUG RESISTANCE IN HUMAN COLORECTAL CARCINOMA 97
Ruolo del signaling dell’EGF nel fenotipo angiogenetico del carcinoma indifferenziato della tiroide: implicazioni terapeutiche 96
Tripla modulazione del 5-Fluorouracile (5-FU) con Methotrexate (MTX), Acido Folinico (FA) e Cisplatino (CDDP) nella terapia dell’adenocarcinoma gastrico in fase avanzata: studio di fase II 93
Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells. 92
Trap1, a novel antiapoptotic gene responsible for multidrug resi stance in human colorectal carcinoma cells. 91
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 91
Cooperation between FGF1 and a soluble form of the notch ligand, Jagged-1, is required for a cell transformation. 90
TRAP1 favor glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 90
Gli inibitori della retrotrascrittasi inducono l'espressione di TPO e Tireoglobulina in colture primarie di carcinoma indifferenziato della tiroide 89
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 89
IRON REQUIREMENT FOR MnSOD GENE ACTIVATION IN MAMMALIAN CELLS. 87
Life-threatening oxaliplatin-induced acute thrombocytopenia, hemolysis and bleeding: a case report. 86
Copper Induces the Assembly of a Multiprotein Aggregate Implicated in the Release of FGF1 in Response to Stress. 86
The Nrf2 transcription factor contributes to the induction of alpha-class GST isoenzymes in liver of acute cadmium or manganese intoxicated rats: comparison with the toxic effect on NAD(P)H:quinone reductase. 85
Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. 85
RE-INDUCTION OF CELL DIFFERENTIATION AND 131I UPTAKE IN A POORLY-DIFFERENTIATED THYROID TUMOUR IN RESPONSE TO THE REVERSE TRANSCRIPTASE INHIBITOR NEVIRAPINE 85
Vinorelbine and alternating cisplatin and ifosfamide in the treatment of non-small cell lung cancer. 84
Altered gene expression of MnSOD in Hepatocarcinomas. 84
BRAF V600E and KRAS G12R mutations correlate with Sunitinib resistance in thyroid cancer cell lines. 84
Anti-tumor Activity of non-Nucleosidic Reverse Transcriptase Inhibitors 83
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 83
TRAP1, a novel antiapoptotic gene responsible for multidrug resistance. 82
Meccanismi molecolari coinvolti nell’azione differenziante della nevirapina nel carcinoma indifferenziato della tiroide. 82
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP-6 81
Amlexanox reversibly inhibits cell migration and proliferation and induces the Src-dependent disassembly of actin stress fiber in vitro. 80
PRECLINICAL EVIDENCES ON THE ACTIVITY OF EGFR1 INHIBITORS IN POORLY-DIFFERENTIATED THYROID CARCINOMA CELLS 80
TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: Relevance in human colorectal tumors. 80
The role of human chorionic gonadotropin as tumor marker: Biochemical and clinical aspects 80
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6 80
TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells 79
A role of endogenous Reverse Transcriptase activity in embryo development and in tumor cell growth and differentiation 79
THE REVERSE TRANSCRIPTASE INHIBITOR NEVIRAPINE RE-INDUCES CELL DIFFERENTIATION AND 131I UPTAKE IN A POORLY-DIFFERENTIATED THYROID TUMOUR 79
RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study 79
Trap-1, a novel antiapoptotic gene responsible for resistance to chemotherapeutic agents in human colorectal carcinoma. 78
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma 78
The levels of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanism and clinical implications. 77
Diethyldithiocarbamate treatment up-regulates manganese superoxidedismutase gene expression in rat liver. 77
Preparation of a monoclonal antibody against rat MnSOD, using a COOH-terminal peptide. 77
COMPARATIVE GENE EXPRESSION PROFILING OF TOBACCO-ASSOCIATED HPV-POSITIVE VERSUS NEGATIVE ORAL SQUAMOUS CARCINOMA CELL LINES. 77
Variation of MnSOD in rat experimental tumors detected by western blot analysis with a new monoclonal antibody. 76
Inhibition of cell proliferation by amlexanox correlates with cortactin phosphorylation and cyclin D1 down-regulation independent of MAPK activation. 76
NOTCH SIGNALLING MODULATES HYPOXIA-INDUCED NEUROENDOCRINE DIFFERENTIATION OF HUMAN PROSTATE CANCER CELLS 76
The precursor but not the mature form of IL1alpha blocks the release of FGF1 in response to heat shock. 75
S100A13 is a new angiogenic marker in human melanoma 75
Induction of MnSOD by ethanol administration in rat liver. 75
Nevirapine restores hormone sensitivity in undifferentiated androgen-refractory prostate carcinoma cells 75
Amlexanox induces the reversible attenuation of F-acitin stress fibers. 75
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines 75
TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 75
Jagged-1-dependent cell chord formation in vitro is modified by src and is resistant to the destabilization of actin stress fibers. 74
Il Sunitinib inibisce la proliferazione di linee di carcinoma tiroideo BRAF e KRAS wild-type. 74
Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1 74
TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma 74
TRAP1 controls cell cycle progression through the regulation of CDK1 and MAD2 expression/ubiquitination in human breast, colon and lung carcinomas. 74
The non-classical export routes: FGF1 and IL-1alpha point the way. 73
bFGF in the angiogenesis of human colorectal cancer. 73
Sorcin induces a drug-resistant phenotype in human colorectal cancer through the modulation of Ca2+ homeostasis. 73
TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways 73
MECHANISM OF DEFECTIVE GENE EXPRESSION OF MNSOD IN CANCER CELLS. 72
Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma 72
Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. 71
Biological mechanisms and clinical significance of angiogenesis in colorectal cancer. 71
Functional characterization of TRAP1 pathway in multidrug resistance in human colorectal carcinoma. 71
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 71
Aumentata espressione della manganese superossidodismutasi in tumori cerebrali neuroectodermici: un nuovo marcatore di progressione? 71
TRAP1 controls cell cycle G2–M transition through the regulation of CDK1 and MAD2 expression/ubiquitination 71
Protein folding does not prevent the non-classical export of FGF1 and S100A13. 70
S100 calcium binding protein A13 70
TRAP1 represent a key mediator of stemness and glycolytic metabolism in colorectal cancer cells 70
Analysis of the mutational status of the BRAF oncogene in familiar non-medullary thyroid carcinomas. 70
Evaluation of Glucose Uptake in Normal and Cancer Cell Lines by Positron Emission Tomography 70
ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features 70
The role of Interferon-a2b in the treatment of advanced colorectal cancer with Folinic acid and 5-Fluorouracil: a randomized study. 69
TMZ and PCV in unresectable high grade gliomas: a retrospective comparison between two common schedules. 69
TRAP1 downregulation in human ovarian cancer enhances invasion and Epithelial-Mesenchymal Transition 69
TRAP1 favors glycolytic metabolism and resistance to EGFR inhibitors in human colorectal carcinoma through regulation of PFK. 69
Monoclonal antibody 35.8 recognizes human, mouse and rat MnSOD in western blot and immunostaining. 68
The role of EGF signaling in the progression toward a poorly-differentiated mesenchymal-like phenotype in thyroid carcinoma cells 68
TRAP1 and sorcin cooperate in a survival pathway responsible for inducing drug-resistance in human colorectal carcinoma. 68
S100A13, a new marker of angiogenesis in brain tumors. 68
bFGF LEVELS IN COLORECTAL CANCER: PRELIMINARY REPORT. 68
Neoadjuvant treatment of metastatic liver disease with irinotecan and 5-fluorouracil (5-FU) plus folinic acid (L-FA) in colorectal cancer patients. 68
Reverse transcriptase inhibitors down-regulate cell proliferation in vitro and in vivo and restore thyrotropin signaling and iodine uptake in human thyroid anaplastic carcinoma 68
TRAP1 and the calcium binding protein sorcin interact in mitochondria and protect cells against apoptosis induced by antiblastic agents. 68
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer 68
Schedule-Dependent Activity of the 5-Fluorouracil and Irinotecan Combination in the Treatment of Human Colorectal Cancer: In Vitro Evidences and a Phase I Dose-escalating Clinical Trial. 68
Treatment of patients with advanced gastric carcinoma with 5-fluorouracil-based or cisplatin-based regimen: two parallel phase II studies. 67
Gli inibitori della retrotrascrittasi attenuano la proliferazione cellulare ed inducono il differenziamento nel carcinoma anaplastico della tiroide 67
Induzione con LPS della Manganese Superossido Dismutasi in HCC di ratto. 67
Iron modulation of LPS induced manganese superoxidedismutase gene expression in rat liver. 66
Soluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like formation. 66
Adaptation to oxidative stress, chemoresistance and cell survival 66
Totale 7.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019297 0 0 0 0 0 0 0 0 0 0 87 210
2019/20203.449 741 410 130 42 435 473 485 44 304 41 296 48
2020/20211.858 273 12 226 18 239 133 296 84 273 278 4 22
2021/20221.187 193 11 15 19 60 20 37 99 176 118 51 388
2022/20235.731 464 209 269 341 381 540 58 436 2.727 34 124 148
2023/2024844 187 41 58 44 100 283 39 68 5 19 0 0
Totale 15.734